Research progress of transmembrane&nbsp;CLDN18.2 in targeted cancer therapy

doi:10.3760/cma.j.issn.1673-4211.2020.01.008

PDF(979 KB)

International Journal of Biologicals ›› 2020, Vol. 43 ›› Issue (1) : 35-40. DOI: 10.3760/cma.j.issn.1673-4211.2020.01.008

Research progress of transmembrane CLDN18.2 in targeted cancer therapy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 43(1): 35-40 https://doi.org/10.3760/cma.j.issn.1673-4211.2020.01.008

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(979 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export